Dr. William H. Kelley, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7069 Us Highway 67 E, Maud, TX 75567 Phone: 903-244-4850 Fax: 903-671-7286 |
News Archive
The newly launched UK Parkinson's Excellence Network can transform care for those affected by Parkinson's, according to an article in Neurodegenerative Disease Management.
SkylineDx, an innovative biotechnology company specialising in the development and commercialization of genetic tests, is today launching its MMprofiler assay. This test enables clinicians to more accurately predict the prognosis of patients with multiple myeloma (bone marrow cancer) than traditional methods.
Waters Corporation introduces today Viridis™ SFC columns, a new family of analytical and preparative supercritical fluid chromatography (SFC) columns. Waters new Viridis SFC columns were developed to give laboratories using SFC a reliable source of high-quality columns for compound purification. Paired with Waters® TharSFC™ instrumentation laboratories now have a single source for both instrumentation and columns for their all-important purification work.
Scientists are learning that a lesser-studied region on the pandemic coronavirus is recognized by COVID-19 infection-fighting antibodies. These antibodies were identified in blood samples from previously infected patients, and were found to potently prevent the virus from infecting cells.
Novo Nordisk A/S and ZymoGenetics, Inc. today announced an agreement where Novo Nordisk in-licenses a fully-human anti-IL21 monoclonal antibody (IL-21 mAb) developed by ZymoGenetics, as well as broad intellectual property rights covering IL-21 mAb and the development of other IL-21 antibodies.
› Verified 6 days ago